NEOT - Neothetics, Inc.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
1.9193
+0.0793 (+4.3098%)
At close: 3:58PM EST
Stock chart is not supported by your current browser
Previous Close1.8400
Open1.9000
Bid0.0000 x 0
Ask0.0000 x 0
Day's Range1.8400 - 1.9392
52 Week Range0.3000 - 2.6300
Volume154,801
Avg. Volume267,490
Market Cap26.583M
Beta3.30
PE Ratio (TTM)N/A
EPS (TTM)-0.6940
Earnings DateMar 21, 2018 - Mar 26, 2018
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est3.00
Trade prices are not sourced from all markets
  • Evofem Announces Closing Of Merger With Neothetics
    PR Newswirelast month

    Evofem Announces Closing Of Merger With Neothetics

    SAN DIEGO, Jan. 17, 2018 /PRNewswire/ -- Evofem Biosciences, Inc. (NASDAQ:EVFM), today announced the closing of the previously announced merger with Neothetics, Inc. (NEOT).  The merged company will operate as Evofem Biosciences, Inc. and will focus on the continued development and commercialization of women's healthcare products.  The company will be led by the current Evofem management team under the leadership of Saundra Pelletier, Chief Executive Officer.  The stock will trade on the Nasdaq Capital Market beginning on Thursday, January 18, 2018 under the ticker symbol "EVFM" and was assigned a new CUSIP number 30048L 104. "The closing of this merger marks a significant milestone for Evofem, an achievement made possible only through the dedication and commitment of our management team and unwavering support of our investors," said Saundra Pelletier, CEO of Evofem Biosciences.

  • GlobeNewswire2 months ago

    Neothetics Announces Adjournment of Special Stockholders Meeting to Solicit Additional Votes for Merger With Evofem

    SAN DIEGO, Jan. 05, 2018-- Neothetics, Inc. today announced that the Special Meeting of Stockholders held earlier today was convened and adjourned without any business being conducted other than the adjournment. ...

  • Should You Be Concerned About Neothetics Inc’s (NEOT) Risks?
    Simply Wall St.2 months ago

    Should You Be Concerned About Neothetics Inc’s (NEOT) Risks?

    For Neothetics Inc’s (NASDAQ:NEOT) shareholders, and also potential investors in the stock, understanding how the stock’s risk and return characteristics can impact your portfolio is important. The beta measures NEOT’sRead More...

  • Who Are The Major Shareholders In Neothetics Inc (NEOT)?
    Simply Wall St.3 months ago

    Who Are The Major Shareholders In Neothetics Inc (NEOT)?

    Today, I will be analyzing Neothetics Inc’s (NASDAQ:NEOT) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have an impact on shareholderRead More...

  • GlobeNewswire3 months ago

    Recent Analysis Shows Aflac, Biogen, Oasis Petroleum, Twilio, Neothetics, and McDonald's Market Influences — Renewed Outlook, Key Drivers of Growth

    NEW YORK, Nov. 29, 2017-- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Aflac ...

  • Associated Press3 months ago

    Neothetics reports 3Q loss

    The San Diego-based company said it had a loss of 13 cents per share. The company's shares closed at $1.24. A year ago, they were trading at $1.16. _____ This story was generated by Automated Insights ...

  • Have Investors Already Priced In Healthcare Growth For Neothetics Inc (NEOT)?
    Simply Wall St.4 months ago

    Have Investors Already Priced In Healthcare Growth For Neothetics Inc (NEOT)?

    Neothetics Inc (NASDAQ:NEOT), a USD$17.15M small-cap, operates in the healthcare industry, which faces key trends such as rising demand fuelled by an aging population and the growing prevalence of chronicRead More...

  • ACCESSWIRE4 months ago

    Today's Research Reports on Stocks to Watch: Neothetics, Inc. and Diffusion Pharmaceuticals

    NEW YORK, NY / ACCESSWIRE / October 18, 2017 / Shares of Neothetics and Diffusion Pharmaceuticals saw big gains in Tuesday trading after the companies had positive news respectively. Neothetics soared ...

  • Neothetics Inc (NEOT): How Does It Impact Your Portfolio?
    Simply Wall St.5 months ago

    Neothetics Inc (NEOT): How Does It Impact Your Portfolio?

    If you are looking to invest in Neothetics Inc’s (NASDAQ:NEOT), or currently own the stock, then you need to understand its beta in order to understand how it can affectRead More...

  • Associated Press6 months ago

    Neothetics reports 2Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 20 cents. The company's shares closed at 46 cents. A year ago, they were trading at $1.01. _____ This story was generated by Automated ...

  • Zacks8 months ago

    Neothetics' Fat Reduction Candidate Fails in Phase II Study

    Neothetics, Inc. (NEOT) announced disappointing top line results from a phase II proof-of-concept study, LIPO-202-CL-31, evaluating its lead candidate, LIPO-202, for reduction of submental subcutaneous fat.

  • Associated Press9 months ago

    Neothetics reports 1Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 22 cents. The company's shares closed at $2.10. A year ago, they were trading at 94 cents. _____ This story was generated by Automated ...

  • Accesswire11 months ago

    Today's Research Reports on Biotech Stocks to Watch: Corvus Pharmaceuticals and Neothetics

    NEW YORK, NY / ACCESSWIRE / April 6, 2017 / Corvus Pharmaceuticals and Neothetics have recently reported some interesting news for investors. Corvus continues to move CPI-444 in FDA clinical trials, while ...

  • 24/7 Wall St.11 months ago

    Neothetics Posts Solid Win on Patent Approval

    Neothetics saw its stock hit a multiyear high on Wednesday after the firm announced a critical patent approval.

  • Associated Press11 months ago

    Neothetics reports 4Q loss

    On a per-share basis, the San Diego-based company said it had a loss of 14 cents. For the year, the company reported a loss of $13 million, or 94 cents per share. The company's shares closed at $1.43. ...